InvestorsHub Logo
Followers 17
Posts 2021
Boards Moderated 0
Alias Born 02/26/2011

Re: Silvr Surfr post# 37598

Thursday, 01/12/2012 9:26:10 PM

Thursday, January 12, 2012 9:26:10 PM

Post# of 92948
Wrong. Curing spinal cord injuries is vastly more complicated than halting macular degeneration. And takes far more time to see results. Plus eye is immuno-privileged site (doesn't reject and require immuno-suppressants). Furthermore, the number of people suffering from macular-degeneration is huge, whereas those with spinal cord injuries make up a very small pool of patients.

Stem cells were only the wrong path for Gern, in particular, (to survive at this time in their development). They had to choose one focus that would give them the fastest results. But it is NOT a "wrong path" for ACTC! For ACTC it is totally the *RIGHT* path and is going to succeed beyond anyone's wildest dreams! Not only with eye disease cures. Also heart, blood and much more.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.